Tumor-targeted gene delivery: an attractive strategy to use highly active effector molecules in cancer treatment
- 22 May 2002
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 9 (11) , 731-735
- https://doi.org/10.1038/sj.gt.3301748
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Different Strategies for Formation of PEGylated EGF-Conjugated PEI/DNA Complexes for Targeted Gene DeliveryBioconjugate Chemistry, 2001
- Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic applicationGene Therapy, 2001
- Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirusGene Therapy, 2000
- Polycation-based DNA complexes for tumor-targeted gene deliveryin vivoThe Journal of Gene Medicine, 1999
- Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathwayGene Therapy, 1999
- Polyethylenimine-based intravenous delivery of transgenes to mouse lungGene Therapy, 1998
- Coupling of cell-binding ligands to polyethylenimine for targeted gene deliveryGene Therapy, 1997
- Targeting gene expression to hypoxic tumor cellsNature Medicine, 1997
- A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.Proceedings of the National Academy of Sciences, 1995
- Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosisAdvanced Drug Delivery Reviews, 1994